Back to List View Graph View

Mitogen-Activated Protein Kinase 1 (MAPK1)

MAPK1 encodes mitogen-activated protein kinase 1, also known as ERK2, a serine/threonine kinase in the MAPK/ERK signaling cascade.

Where the papers sit

12 papers from the last 6 months study Mitogen-Activated Protein Kinase 1 (MAPK1) directly · updated from PubMed 7 Nov 2026

Study type 0 clinical trials · 2 human data · 8 preclinical · 2 unclassified

Themes no clear themes

Those 12 do not share a common subject.

  • Cancer drug discovery, pain biology, metabolic disease, aging, plant chemistry and experimental methods occupy this group. Individual studies address SHP2, Aurora A/ERK, KRAS metabolism, cuproptosis, CGRP signaling and CRISPR mutagenesis. The findings do not converge on a shared mechanism, disease, therapeutic strategy or endpoint. No overall research direction can be inferred from the cluster.

    12 papers

Papers

The 12 papers from the last 6 months that study Mitogen-Activated Protein Kinase 1 (MAPK1) directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.

By theme

No clear themes (12)
  1. Thiadiazolo-Triazolo-Pyrimidine Hybrids as Dual Aurora A/ERK Inhibitors: Design, Synthesis, and Apoptotic Activity. Drug development research · 19 Aug 2026 PMID 42616559
  2. Discovery and Preclinical Characterization of I-0436650, a Selective SHP2 Allosteric Inhibitor for RAS-Driven Cancers. Journal of medicinal chemistry · 13 Aug 2026 PMID 42593923
  3. Botulinum toxin type A attenuates trigeminal neuralgia-like pain by suppressing CGRP release and modulating NaV1.7-associated signaling. The journal of headache and pain · 11 Aug 2026 PMID 42576205
  4. Nilotinib induces immunogenic cuproptosis to potentiate cancer immunotherapy. Cell reports. Medicine · 22 Jul 2026 PMID 42486098
  5. Safety and efficacy of metformin for the treatment of pain: protocol for a systematic review. BMJ open · 17 Jul 2026 PMID 42468965
  6. KRAS on Empty: Lipid Oxidation Blockade Reveals a Metabolic Achilles' Heel in Pancreatic Cancer. Cancer research · 15 Jul 2026 PMID 42452976
  7. Multi-dimensional profiling of primary metabolites in Heuchera micrantha varieties reveals potential for functional food development. Genomics · 9 Jul 2026 PMID 42425198
  8. Epigallocatechin Gallate Attenuates Arecoline-induced Migration and Invasion in Esophageal Squamous Cell Carcinoma Cells Associated With EGFR/AKT/P38 Signaling. Anticancer research · 29 Jun 2026 PMID 42373249
  9. Deciphering protein mutation-phenotype linkages from CRISPR-based tiling mutagenesis screens. Cell systems · 26 Jun 2026 PMID 42361799
  10. Dual-engineered small extracellular vesicles targeted delivery miR-126 for reducing age-related bone loss. Biomedical materials (Bristol, England) · 17 Jun 2026 PMID 42309139
  11. Coumarin metabolites in Ocimum: chemical diversity, biosynthetic pathways, and network pharmacology-based prediction of multi-target anticancer potential. Plant molecular biology · 3 Jun 2026 PMID 42236954
  12. Butyrate Regulates the Blood-Brain Barrier Transport and Intraendothelial Accumulation of Alzheimer's Disease Amyloid-Beta Peptides. Molecular pharmaceutics · 21 May 2026 PMID 42166642

By study type

Human data, design not indexed (2)
  1. Safety and efficacy of metformin for the treatment of pain: protocol for a systematic review. BMJ open · 17 Jul 2026 PMID 42468965
  2. Deciphering protein mutation-phenotype linkages from CRISPR-based tiling mutagenesis screens. Cell systems · 26 Jun 2026 PMID 42361799
Preclinical: animal, cell and lab studies (8)
  1. Thiadiazolo-Triazolo-Pyrimidine Hybrids as Dual Aurora A/ERK Inhibitors: Design, Synthesis, and Apoptotic Activity. Drug development research · 19 Aug 2026 PMID 42616559
  2. Discovery and Preclinical Characterization of I-0436650, a Selective SHP2 Allosteric Inhibitor for RAS-Driven Cancers. Journal of medicinal chemistry · 13 Aug 2026 PMID 42593923
  3. Botulinum toxin type A attenuates trigeminal neuralgia-like pain by suppressing CGRP release and modulating NaV1.7-associated signaling. The journal of headache and pain · 11 Aug 2026 PMID 42576205
  4. Nilotinib induces immunogenic cuproptosis to potentiate cancer immunotherapy. Cell reports. Medicine · 22 Jul 2026 PMID 42486098
  5. KRAS on Empty: Lipid Oxidation Blockade Reveals a Metabolic Achilles' Heel in Pancreatic Cancer. Cancer research · 15 Jul 2026 PMID 42452976
  6. Epigallocatechin Gallate Attenuates Arecoline-induced Migration and Invasion in Esophageal Squamous Cell Carcinoma Cells Associated With EGFR/AKT/P38 Signaling. Anticancer research · 29 Jun 2026 PMID 42373249
  7. Dual-engineered small extracellular vesicles targeted delivery miR-126 for reducing age-related bone loss. Biomedical materials (Bristol, England) · 17 Jun 2026 PMID 42309139
  8. Butyrate Regulates the Blood-Brain Barrier Transport and Intraendothelial Accumulation of Alzheimer's Disease Amyloid-Beta Peptides. Molecular pharmaceutics · 21 May 2026 PMID 42166642
Unclassified: not yet indexed with MeSH (2)
  1. Multi-dimensional profiling of primary metabolites in Heuchera micrantha varieties reveals potential for functional food development. Genomics · 9 Jul 2026 PMID 42425198
  2. Coumarin metabolites in Ocimum: chemical diversity, biosynthetic pathways, and network pharmacology-based prediction of multi-target anticancer potential. Plant molecular biology · 3 Jun 2026 PMID 42236954